Document:

EX-10.3

 Exhibit 10.3 

EMPLOYMENT AGREEMENT 
 THIS EMPLOYMENT
AGREEMENT is made and entered into as of this 6th day of November 2014, by and between Unilife Corporation (“Unilife”) and Mark V. Iampietro (“Iampietro”). The term “Unilife” shall include its subsidiaries,
affiliates, assigns and successors in interest under Sections 7, 8, and 13. 
 WHEREAS, Unilife is engaged in the business of designing, developing,
manufacturing and supplying advanced drug delivery systems; 
 WHEREAS, Unilife has employed Iampietro as Vice President, Corporate Quality and
Regulatory Affairs since October 2008; 
 WHEREAS, Unilife wishes to replace the employment agreement entered into by the parties on
November 10, 2009 and extend the employment of Iampietro as Vice President, Corporate Quality and Regulatory Affairs and Chief Compliance Officer, and Iampietro wishes to extend the term of his employment with Unilife; and 

WHEREAS, Unilife and Iampietro wish to enter into this employment agreement to set forth the terms of Iampietro’s continued employment
relationship with Unilife. 
 NOW, THEREFORE, in consideration of the promises and covenants set forth herein, and intending to be legally bound
hereby, the parties agree as follows: 
 1. Term. This agreement shall be effective as of the date of this agreement and shall be for a multi-year
term commencing on such effective date and expiring on December 31, 2018. This agreement will automatically renew for one-year periods annually thereafter, unless either party gives the other party thirty (30) days written notice in
advance of the relevant expiration date of its intention not to renew the agreement. Upon expiration or earlier termination of this employment relationship, the parties will be relieved of their duties and obligations under this agreement, except
that the rights and obligations of Unilife under Section 6 below shall remain in full force and effect until all appropriate payments have been made to Iampietro and the rights and obligations of Iampietro set forth in Sections 7 and 8 below
shall remain in full force and effect and shall survive the expiration or termination of this agreement, regardless of the reason(s) for termination. 
 2.
Position and Duties. 
 (a) Unilife will employ Iampietro as Vice President, Corporate Quality and Regulatory Affairs and Chief
Compliance Officer, and Iampietro agrees to serve in such capacity for Unilife with responsibility for Unilife’s corporate quality and regulatory affairs and such other duties as are assigned to him by the Chief Executive Officer
(“CEO”) of Unilife, and shall have vested in him the authority and duties typically held by an employee in such position. Iampietro shall report to the Chief Executive Officer with respect to the performance of these duties and shall be a
member of the Executive Team. In the performance of these duties, Iampietro shall devote his knowledge, skill, attention, energies and all of his business time, and shall comply with all of Unilife’s policies, rules, and procedures, as they may
be amended from time to time. Iampietro shall not engage in any endeavor that would conflict with the rendition of his services to Unilife, either directly or indirectly, without the prior written consent of Unilife’s CEO; provided, however,

  

					
		 	Page 1 of 13	  	

		 		  

 
Iampietro may participate in civic, charitable, educational, industry and professional organizations, to the extent that such participation does not unreasonably interfere with the performance of
his duties hereunder; and Iampietro may also serve on corporate boards and committees, but only with the prior written consent of Unilife’s CEO. 

(b) Notwithstanding the responsibilities and duties contained in Section 2(a) above, Iampietro acknowledges that all material decisions
relating to the management of Unilife’s business will be made by the CEO or the Board of Directors of Unilife. In addition, any decisions which have the capacity to affect significantly the financial standing of Unilife must be referred to the
CEO or Board of Directors of Unilife who will have ultimate control in respect of these matters. 
 3. Compensation. 

(a) Base Salary. Iampietro shall be paid an annual base salary of Two Hundred Forty-Two Thousand Dollars ($242,000) payable in
accordance with Unilife’s standard payroll practices. Iampietro’s base salary will be subject to the customary withholding and employment taxes, as required by law, with respect to compensation paid by an employer to an employee. At the
discretion of the Compensation Committee of the Board of Directors of Unilife (the “Compensation Committee”), Iampietro shall be eligible for increases in base salary. Further, Unilife will not reduce Iampietro’s base salary to less
than what is agreed to herein. 
 (b) Bonus. Iampietro shall be eligible to participate in Unilife’s Incentive Bonus Plan in
amounts and percentages as determined by Unilife’s Compensation Committee. The target cash bonus amount for such bonus will be thirty-five percent (35%) of base salary. Bonuses are subject to achievement of such goals and objectives as the
Compensation Committee determines in a set of Key Performance Indicators. Any bonus payable for a fiscal or calendar year shall be paid in a lump-sum payment no later than the date that is two and one-half months after the close of the relevant
fiscal or calendar year. Iampietro’s bonuses will be subject to the customary withholding and employment taxes, as required by law, with respect to compensation paid by an employer to an employee. 

4. Benefits. 
 (a) Benefits Generally
Available to Unilife Employees. Iampietro shall be eligible to participate in Unilife’s benefits programs (including any equity incentive plan of Unilife or its affiliates), as they may change from time to time. The benefits provided to
Iampietro will be the same as the benefits provided to other similarly situated Unilife employees, and may be changed upon expiration or other termination of the current benefits contracts. For further information, Iampietro should review any
applicable benefit plan documents, which will govern the terms of the benefits. 
 (b) Vacation. Iampietro shall also receive four
(4) weeks of paid vacation per calendar year. Any unused vacation days may be carried over or paid in lieu thereof, to the extent allowed by Unilife’s policy for similarly situated employees or at the CEO’s discretion. 

(c) Equity Plans. Any stock options and other stock-based awards that Iampietro may receive from Unilife shall be governed by the
applicable, underlying award agreement and the terms of the 2009 Stock Incentive Plan or any successor plan under which the award is granted. 

(d) Expenses. Unilife shall reimburse Iampietro for all reasonable and necessary expenses incurred by him in carrying out his duties
under this agreement in accordance with Unilife’s business expense policies, including without limitation, requirements with respect to reporting, documentation and payment of such expenses. All such expenses shall be paid promptly after
submission in accordance with Unilife’s polices, but no later than December 31st of the calendar year following the year in which such expenses were incurred. 

  

					
		 	Page 2 of 13	  	

		 		  

 5. Indemnification. Unilife agrees to provide Iampietro with indemnification equivalent to that provided to other
members of senior management and insurance coverage pursuant to Unilife’s Directors and Officers insurance policies, as amended from time to time. 

6. Termination and Pay upon Termination. 

(a) General Rule. In the event that Unilife terminates this agreement and Iampietro’s employment without Cause as defined herein,
including employment termination due to Unilife’s election not to renew this agreement where Iampietro was willing and able to continue performing services under the terms of this agreement, Unilife will pay Iampietro the severance benefits
provided in subparagraphs (i) through (iv) of this Section 6(a). 
 (i) his base salary, at the rate in effect
immediately before the date that Iampietro’s employment terminates, for twelve (12) months, in accordance with Unilife’s standard payroll practices then in effect, commencing on the fifteenth (15th) day after the date that
Iampietro’s employment terminates and the General Release provided for in Section 9 of this Agreement becomes irrevocable; 

(ii) provided that Iampietro is eligible for and timely elects to receive COBRA health, vision and dental care continuation
coverage, the cost of Iampietro’s COBRA health, vision and dental care continuation coverage premiums (for himself and his eligible dependents) for twelve (12) months, commencing on the first of the month immediately after the month which
includes the date that Iampietro’s employment terminates and the General Release provided for in Section 9 of this agreement becomes irrevocable; 

(iii) payment of an amount, equal to the greater of the amount of the bonus, if any, earned by and paid to Iampietro for the
last completed bonus year prior to the year in which his employment terminates or the target bonus for which Iampietro was eligible to earn in the bonus year in which his employment is terminated, which will be payable in equal installments over a
twelve (12) month period, in accordance with Unilife’s standard payroll practices then in effect, commencing on the fifteenth (15th) day after the date that Iampietro’s employment
terminates and the General Release provided for in Section 9 of this Agreement becomes irrevocable; and 
 (iv)
notwithstanding anything to the contrary, all of Iampietro’s outstanding and unvested options and other stock-based awards shall vest immediately upon such termination of employment without Cause. 

In the event that Iampietro terminates this agreement for any reason, including Iampietro’s election not to renew the agreement, Iampietro shall not
receive any compensation or benefits from the time that he ceases to devote full time and attention to Unilife’s business, except such 

  

					
		 	Page 3 of 13	  	

		 		  

 
compensation as was earned prior to that date, including, but not limited to unused vacation and vested equity grants. In addition, Iampietro agrees to provide Unilife with thirty (30) days
advance written notice of his intent to terminate his employment, whether during the initial term or any renewal thereof. Upon termination of this agreement, the parties will be relieved of their duties and obligations, except that the rights and
obligations of Unilife under this Section 6(a) shall remain in full force and effect until all appropriate payments have been made to Iampietro, if applicable, and the rights and obligations of Iampietro set forth in Sections 7 and 8 below
shall remain in full force and effect and shall survive the expiration or termination of this agreement, regardless of the reason(s) for termination. Upon termination of this agreement, Iampietro shall not have any further contact with any customers
of Unilife on behalf of a competing entity until the expiration of the conditions of Section 8 of this agreement. 
 (b) Termination
Following a Change in Control. 
 (i) Termination Pay. Notwithstanding paragraph (a) immediately above, in
the event that Unilife terminates this agreement and Iampietro’s employment without Cause as defined herein, including employment termination due to Unilife’s election not to renew this agreement where Iampietro was willing and able to
continue performing services under the terms of this agreement, in either case coincident with or within twelve months after a Change in Control as defined in subparagraph (iii) immediately below, then Unilife, in lieu of and not in duplication
of the severance compensation provided for in paragraph (a) immediately above, shall pay Iampietro: 
 (A) his base
salary, at the rate in effect immediately before the date that Iampietro’s employment terminates, for eighteen (18) months, in accordance with Unilife’s standard payroll practices then in effect, commencing on the fifteenth (15th) day after the date that Iampietro’s employment terminates and the General Release provided for in Section 9 of this Agreement becomes irrevocable, 

(B) provided that Iampietro is eligible for and timely elects to receive COBRA health, vision and dental care continuation
coverage, the cost of Iampietro’s COBRA health, vision and dental care continuation coverage premiums (for himself and his eligible dependents) for eighteen (18) months, commencing on with the first of the month immediately after the month
which includes the date that Iampietro’s employment terminates and the General Release provided for in Section 9 of this Agreement becomes irrevocable, 

(C) payment of a lump-sum amount, equal to the greater of the amount of the bonus, if any, earned by and paid to Iampietro for
the last completed bonus year prior to the year in which his employment terminates or the target bonus for which Iampietro was eligible to earn in the bonus year in which his employment is terminated, which will be payable on the fifteenth (15th) day after the date that Iampietro’s employment terminates and the General Release provided for in Section 9 of this Agreement becomes irrevocable, and 

(D) notwithstanding anything to the contrary, all of Iampietro’s outstanding and unvested options and other stock-based
awards shall vest immediately upon a Change in Control. 

  

					
		 	Page 4 of 13	  	

		 		  

 (ii) Definition of “Cause”. “Cause” will mean any one or more
of the following: 
 (A) material neglect of assigned duties, willful misconduct in connection with the performance of
duties, or refusal to perform assigned duties (other than by reason of disability) which continues uncured for thirty (30) days following receipt of written notice of such deficiency from the CEO, specifying the scope and nature of the
deficiency; 
 (8) engaging in any act of dishonesty, any act of moral turpitude, any illegal conduct or committing a crime
that causes material harm to Unilife or its reputation; 
 (C) being barred from working in a Food and Drug Administration
(“FDA”) regulated industry by the FDA or otherwise being sanctioned by the FDA or any similar international body; 

(D) breaching, in any material respect, the terms of any agreement with Unilife; or 

(E) commencement of employment with any other employer while an employee of Unilife without the prior written consent of the
CEO. 
 Any determination of “Cause” as used herein will be made in good faith by the CEO. 

(iii) Definition of “Change in Control”. “Change in Control” means a: (i) Change in Ownership
of Unilife Corporation, (ii) Change in Effective Control of Unilife Corporation, or a (iii) Change in the Ownership of Assets of Unilife Corporation, all as described herein and construed in accordance with section 409A of the Internal
Revenue Code of 1986, as amended (the “Code”). 
 (A) A Change in Ownership of Unilife Corporation shall occur on
the date that any one Person acquires, or Persons Acting as a Group (or Group) acquire, ownership of the capital stock of Unilife Corporation that, together with the stock held by such Person or Group, constitutes more than fifty percent
(50%) of the total fair market value or total voting power of the capital stock of Unilife Corporation. However, if any one Person is, or Persons Acting as a Group are, considered to own more than fifty percent (50%) of the total fair
market value or total voting power of the capital stock of Unilife Corporation, the acquisition of additional stock by the same Person or Persons Acting as a Group is not considered to cause a Change in Ownership of Unilife Corporation or to cause a
Change in Effective Control of Unilife Corporation. An increase in the percentage of capital stock owned by any one Person, or Persons Acting as a Group, as a result of a transaction in which Unilife Corporation acquires its stock in exchange for
property will be treated as an acquisition of stock. 
 (8) A Change in Effective Control of Unilife Corporation shall occur
on the date a majority of members of the Board of Directors of Unilife Corporation is replaced during any twelve (12)-month period by directors whose appointment or election is not endorsed by a majority of the members of the Board of Directors of
Unilife Corporation before the date of the appointment or election. 

  

					
		 	Page 5 of 13	  	

		 		  

 (C) A Change in the Ownership of Assets of Unilife Corporation shall occur on the
date that any one Person acquires, or Persons Acting as a Group acquire (or has or have acquired during the twelve (12)-month period ending on the date of the most recent acquisition by such Person or Persons), assets (including tangible/real
property and intangible property (such as goodwill)) from Unilife Corporation the total gross fair market value of which is more than fifty percent (50%) of the total gross fair market value of all of the assets of Unilife Corporation
immediately before such acquisition or acquisitions. For this purpose, gross fair market value means the value of the assets of Unilife Corporation, or the value of the assets being disposed of, determined without regard to any liabilities
associated with such assets. 
 (1) The following rules of construction apply in interpreting the definition of Change in
Control: 
 (I) A Person means any individual, entity or group within the meaning of Section 13(d) (3) or 14(d)
(2) of the Securities Exchange Act of 1934, as amended, other than employee benefit plans sponsored or maintained by Unilife Corporation and by entities controlled by Unilife Corporation or an underwriter of the capital stock of Unilife
Corporation in a registered public offering. 
 (II) Persons will be considered to be Persons Acting as a Group if they are
owners of a corporation that enters into a merger, consolidation, purchase or acquisition of stock, or similar business transaction with the corporation. If a Person owns stock in both corporations that enter into a merger, consolidation, purchase
or acquisition of stock, or similar transaction, such shareholder is considered to be acting as a Group with other shareholders only with respect to the ownership in that corporation before the transaction giving rise to the change and not with
respect to the ownership interest in the other corporation. Persons will not be considered to be acting as a Group solely because they purchase assets of the same corporation at the same time or purchase or own stock of the same corporation at the
same time, or as a result of the same public offering. 
 (III) For purposes of this Section 6(b), fair market value
shall be determined in accordance with Code Section 409A. 
 (IV) A Change in Control shall not include a transfer to a
related person as described in Code section 409A or a public offering of capital stock of Unilife Corporation. 
 (E) For
purposes of this Section 6(b), Code section 318(a) applies to determine stock ownership. Stock underlying a vested option is considered owned by the individual who holds the vested option (and the stock underlying an unvested option is not
considered owned by the individual who holds the 

  

					
		 	Page 6 of 13	  	

		 		  

 
unvested option). For purposes of the preceding sentence, however, if a vested option is exercisable for stock that is not substantially vested (as defined by Treasury Regulation §1.83-3(b)
and 0)), the stock underlying the option is not treated as owned by the individual who holds the option. 
 7. Confidential Information. 

(a) Iampietro acknowledges that Unilife has a valuable property interest in all aspects of its business relationships with its customers,
clients, vendors and suppliers. In the course of Iampietro’s work with Unilife, Iampietro will become aware of and familiar with secret and confidential information of Unilife relating to its customers, clients, vendors and suppliers, and its
internal business operations. Secret and confidential information includes, but is not limited to, Unilife’s business plans, customer lists, customer data, marketing plans, supplier and vendor lists and cost information, software and computer
programs, data processing systems and information contained therein, financial statements, financial data, acquisition and divestiture plans, and any other trade secrets or confidential or proprietary information, documents, reports, plans, or data,
of or about Unilife that is not already available to the public or was known to Iampietro prior to his employment with Unilife. 
 (b)
Iampietro agrees that he will not, without the written consent of Unilife, during the term of this agreement or thereafter, disclose or make any use of secret and confidential information, except as may be required in the performance of his duties
under Section 2 of this agreement. Iampietro agrees that, following the termination of his employment with Unilife for any reason, he will never use secret and confidential information to compete with Unilife in any manner, and he will never
disclose any secret and confidential information to any other business or individual, unless such secret or confidential information is: (i) publicly known through no breach of the provisions of this Section 7 by either party,
(ii) lawfully disclosed by a third party, or (iii) disclosed pursuant to legal requirement or court order. In no event shall any disclosure made to investment banking firms or private equity firms at the request of Unilife and as part of
Iampietro’s duties ever be considered a violation of this Section 7. 
 (c) Upon termination of this agreement, Iampietro shall
surrender to Unilife all records and all paper and/or electronic copies made of those records that pertain to any aspect of the business of Unilife, including all secret and confidential information. 

8. Agreement Not To Compete. 
 (a) In
consideration for employment by Unilife and the benefits of this agreement, Iampietro agrees to be bound by the covenant not to compete as set forth in Section 8 of this agreement below; provided however, this non-compete covenant will extend
for a period of two (2) years post-employment, if Iampietro resigns his employment with Unilife or if Unilife terminates Iampietro’s employment for Cause, and provided further that this non-compete covenant will extend for a period of one
(1) year post-employment if Iampietro’s employment with Unilife is terminated by Unilife for any reason, other than Cause. 

  

					
		 	Page 7 of 13	  	

		 		  

 (b) Iampietro agrees that during the term of his employment, other than as precluded by
applicable rules of professional conduct applicable to lawyers including Pennsylvania Rule of Professional Conduct 5.6, he will not, directly or indirectly: 

(i) render services to, become employed by, be engaged as a consultant by, own, or have a financial or other interest in
(either as an individual, partner, joint venture, owner, manager, employee, partner, officer, director, independent contractor, or other similar role) any business that is engaged in any business activity that is in direct competition with the
activities of Unilife, as of the date of the termination of this agreement. 
 (ii) induce, offer, assist, encourage, or
suggest that another business or enterprise offer employment to or enter into a consulting arrangement with any individual who is employed by Unilife, or induce, offer, assist, encourage, or suggest that any Unilife employee terminate his or her
employment with Unilife, or accept employment with any other business or enterprise. 
 (c) In the event that Iampietro commits any breach
of Section 8(b) above, Iampietro acknowledges that Unilife would suffer substantial and irreparable harm and damages. Accordingly, Iampietro hereby agrees that in such event, Unilife shall be entitled to temporary and/or permanent injunctive
relief, without the necessity of proving damage, to enforce the provisions of this Section, all without prejudice to any and all other remedies that Unilife may have at law or in equity and that Unilife may elect or invoke. Iampietro agrees that if
any of the provisions of this Section are or become unenforceable, the remainder hereof shall nevertheless remain binding upon him to the fullest extent possible, taking into consideration the purposes and spirit of this agreement. Any invalid or
unenforceable provision is to be reformed to the maximum time, geographic and/or business limitations permitted by applicable laws, so as to be valid and enforceable. 

(d) Iampietro expressly acknowledges and agrees that the restrictive covenants set forth in Sections 7 and 8 above are absolutely necessary to
protect the legitimate business interests of Unilife, because he is employed in a position of trust and confidence and is provided with extensive access to Unilife’s most confidential and proprietary trade secrets, and has significant
involvement in important business relationships, which constitute the goodwill of Unilife. Iampietro further agrees and acknowledges that these restrictive covenants are reasonable, will not restrict him from earning a livelihood following the
termination of employment, and are intended by the parties to be enforceable following termination of employment for any reason. 
 (e) In
the event that Unilife must bring legal action to enforce or seek a remedy for any breach of the provisions of Sections 7 or 8 of this agreement and Iampietro is found by a court to have breached any of these provisions, Iampietro agrees to
reimburse Unilife for any and all expenses, including attorneys’ fees and court costs, incurred by it in enforcing the terms of these Sections of the agreement. 

9. General Release. As a condition of receiving the severance compensation and benefits described in Section 6, Unilife and Iampietro will execute
a mutual general release of claims (which is in a form acceptable to Unilife); provided that, to the extent that any claim that Unilife may have against Iampietro would not be covered under the D&O insurance of Unilife, then Unilife would not
release such claim under the mutual release. Such general release would not include rights to previously vested options or claims for any compensation or benefits earned (including, without limitation, unused vacation), or reimbursement of expenses
incurred, through the date of termination. Such release must be agreed to, executed and irrevocable no later than 30 days following Iampietro’s termination date. 

  

					
		 	Page 8 of 13	  	

		 		  

 10. Dispute Resolution. Any controversy, claim or dispute involving the parties (or their affiliated persons)
directly or indirectly concerning this agreement shall be finally settled by binding arbitration held in Dauphin County, Pennsylvania by one arbitrator (who is mutually acceptable to both parties as well as licensed to practice law in the
Commonwealth of Pennsylvania) in accordance with the rules of employment arbitration then followed by the American Arbitration Association or any successor to the functions thereof. The arbitrator shall apply Pennsylvania law in the resolution of
all controversies, claims and disputes and shall have the right and authority to determine how his or her decision or determination as to each issue or matter in dispute may be implemented or enforced. Any decision or award of the arbitrator shall
be final and conclusive for both Iampietro and Unilife (and its affiliates), and there shall be no appeal there from other than causes of appeal allowed by the Federal Arbitration Act. Unilife shall bear all costs of the arbitrator in any action
brought under this agreement. The arbitrator shall have the power to award attorney’s fees and arbitration costs to the prevailing party, if the award of attorney’s fees and litigation costs would be permitted by a court. The parties
hereto agree that any action to compel arbitration may be brought in the appropriate Pennsylvania state or federal court, and in connection with such action to compel, the laws of the Commonwealth of Pennsylvania and the Federal Arbitration Act
shall control. Application may also be made to such court for confirmation of any decision or award of the arbitrator, for an order of the enforcement and for any other remedies, which may be necessary to effectuate such decision or award. The
parties hereto hereby consent to the jurisdiction of the arbitrator and of such court and waive any objection to the jurisdiction of such arbitrator and court. 

11. Non-waiver. A waiver of any provision of this agreement by either party shall not prevent either party from enforcing that provision or any other
provision hereof. 
 12. Assignment. This agreement is personal and may not be assigned by Iampietro. Any assignment of this agreement between Unilife (or
its successor) and its affiliates (and their successors) shall not constitute a termination of Iampietro’s employment hereunder. This agreement (including the Restrictive Covenants set forth in Sections 7 and 8) shall inure to the benefit of
and be binding upon any successor to Unilife. The parties specifically understand and agree that the non-compete provisions of Section 8 will inure to the benefit of a successor and that Iampietro will remain bound by these provisions in the
event of a sale or corporate reorganization of Unilife. 
 13. Severability. Each provision of this agreement is severable and distinct from, and
independent of, every other provision hereof. If one provision hereof is declared void, the remaining provisions shall remain in effect. Any provision of this agreement which is prohibited or unenforceable in any jurisdiction shall, as to such
jurisdiction, be ineffective only to the extent of such prohibition or unenforceability without invalidating or affecting the remaining provisions hereof, and any such prohibition or unenforceability in any jurisdiction shall not invalidate or
render unenforceable such provision in any other jurisdiction. 
 14. Entire Agreement. This agreement contains the entire agreement of the parties
concerning the employment relationship and supersedes any prior agreements or understandings between the parties concerning the terms and conditions of Iampietro’s employment, whether oral or written; provided, however, that Iampietro’s
equity grants shall be governed by the equity grant documents; provided further, that any stock options or other stock-based awards provided to Iampietro shall be governed by Unilife’s stock incentive
plans as they are amended from time to time, except as provided herein. The parties acknowledge, in 

  

					
		 	Page 9 of 13	  	

		 		  

 
entering into this agreement that they have not relied upon any promise or inducement not specifically set forth herein. Any changes to this agreement must be in writing and signed by both
parties. 
 15. Section 409A. 
 (a)
This agreement is intended to comply with, or otherwise be exempt from, Code section 409A and any regulations and Treasury guidance promulgated thereunder, and Unilife shall be required to interpret the terms of this agreement as necessary to comply
with the requirements of Code section 409A. 
 (b) Unilife shall undertake to administer, interpret, and construe this agreement in a manner
that does not result in the imposition on Iampietro of any additional tax, penalty, or interest under Code section 409A. 
 (c) Unilife and
Iampietro agree that they will execute any and all amendments to this agreement permitted under applicable law as they mutually agree in good faith may be necessary to ensure compliance with the distribution provisions of Code section 409A or
as otherwise needed to ensure that this agreement complies with that section. 
 (d) The preceding provisions, however, shall not be
construed as a guarantee by Unilife of any particular tax effect to Iampietro under this agreement. Unilife shall not be liable to Iampietro for any payment made under this agreement that is determined to result in an additional tax, penalty, or
interest under Code section 409A, nor for reporting in good faith any payment made under this agreement as an amount includible in gross income under that section. 

(e) For purposes of Code section 409A, the right to a series of installment payments under this agreement shall be treated as a right to a
series of separate payments. 
 (f) With respect to any reimbursement of future expenses of, or any provision of in-kind benefits to,
Iampietro, as specified under this agreement, such reimbursement of expenses or provision of in-kind benefits shall be subject to the following conditions: (i) the expenses eligible for reimbursement or the amount of in-kind benefits provided
in one taxable year shall not affect the expenses eligible for reimbursement or the amount of in-kind benefits provided in any other taxable year, except for any medical reimbursement arrangement providing for the reimbursement of expenses referred
to in Code section 1OS(b); (ii) the reimbursement of an eligible expense shall be made no later than the end of the year after the year in which such expense was incurred; and (iii) the right to reimbursement or in-kind benefits shall not
be subject to liquidation or exchange for another benefit. Any tax gross-up payment shall be made by no later than the end of the calendar year following the year in which Iampietro remits the taxes. 

(g) “Termination of employment,” “resignation,” or words of similar import, as used in this agreement means, for purposes
of any payments under this agreement that are payments of deferred compensation subject to Code section 409A, Iampietro’s “separation from service” as defined in that section. 

(h) If a payment obligation under this agreement arises on account of Iampietro’s separation from service while Iampietro is a
“specified employee” (as defined under Code section 409A and determined in good faith by the Unilife), any payment of “deferred 

  

					
		 	Page 10 of 13	  	

		 		  

 
compensation” (as defined under Treasury regulation section 1.409A-1(b)(1}, after giving effect to the exemptions in Treasury regulation sections 1.409A-1(b)(3) through (b)(12)) that is
scheduled to be paid within six (6) months after such separation from service shall accrue without interest and shall be paid within 15 days after the end of the six-month period beginning on the date of such separation from service or, if
earlier, within 15 days after the appointment of the personal representative or executor of Iampietro’s estate following his death. 

(i) To the extent that under the terms of the agreement the execution of a general release of claims is a condition to Iampietro receiving
severance or other benefits under the agreement, the Company will provide Iampietro with the form of release agreement within seven days after Iampietro’s separation from service. To be entitled to the severance or other benefits, Iampietro
must execute and deliver to the Company the release agreement on or before the last day of the minimum required waiver consideration period provided under the Age Discrimination in Employment Act or other applicable law or such other date as may be
specified in the release agreement. If Iampietro timely delivers an executed release agreement to the Company, and Iampietro does not revoke the release agreement during the minimum revocation period required under applicable law, if any, the
severance or other benefits shall be paid or commence being paid, as applicable, on or after the date on which the release agreement becomes effective as specified in the agreement. If, however, the period during which Iampietro has discretion to
execute or revoke the release agreement straddles two calendar years, no such payment shall be made or benefit provided earlier than the first day of the second such calendar year, regardless of within which calendar year Iampietro actually delivers
the executed release agreement to the Company. Consistent with Section 409A, Iampietro may not, directly or indirectly, designate the calendar year of payment. 

16. Excise Tax on Parachute Payments. Iampietro shall bear all expense of, and be solely responsible for, all federal, state, local or foreign taxes
due with respect to any payment received hereunder, including, without limitation, any excise tax imposed by Code section 4999. Notwithstanding the foregoing, if any payment or distribution by Unilife to or for the benefit of Iampietro, whether paid
or payable or distributed or distributable pursuant to the terms of this Agreement or otherwise pursuant to or by reason of any other agreement, policy, plan, program or arrangement or the lapse or termination of any restriction on or the vesting or
exercisability of any payment or benefit, would be subject to the excise tax imposed by Section 4999 of the Code (or any successor provision thereto) or to any similar tax imposed by state or local law (such tax or taxes are hereafter
collectively referred to as the “Excise Tax”), then the aggregate amount of such payments and benefits (each such payment or benefit, a “Payment”) payable to Iampietro shall be reduced to the aggregate amount of Payments
that may be made to Iampietro without incurring an Excise Tax in accordance with the immediately following sentence; provided that such reduction shall only be imposed if the net after-tax benefit of the Payments retained by Iampietro (after
giving effect to such reduction) is equal to or greater than the net after-tax benefit (after giving effect to the Excise Tax) of the Payments to Iampietro without any such reduction. If the Firm (as defined below) determines that a reduction is
required by this Section 16, then such reduction shall be made in the following order: (i) first, any future cash payments (if any) shall be reduced (if necessary, to zero); (ii) second, any current cash payments shall be reduced (if
necessary, to zero); (iii) third, all non-cash payments (other than equity or equity derivative related payments) shall be reduced (if necessary, to zero); and (iv) fourth, all equity or equity derivative payments shall be reduced. 

For purposes of this Section 16, “net after-tax benefit” shall mean (i) the total of all Payments which Iampietro receives
or is then entitled to receive from Unilife, less (ii) the 

  

					
		 	Page 11 of 13	  	

		 		  

 
amount of all federal, state, local and foreign income taxes payable with respect to such Payment calculated at the maximum marginal income tax rate for each year in which the foregoing shall be
paid to Iampietro (based on the rate in effect for such year as set forth in the Code or other applicable tax law as in effect at the time of the first payment of the foregoing), less (iii) the amount of the applicable Excise Tax, if any,
imposed with respect to the Payment. 
 The foregoing determination shall be made by a nationally recognized human resources consulting or
accounting firm (the “Firm”) selected by Unilife and reasonably acceptable to Iampietro (which may be, but will not be required to be, Unilife’s independent auditors). The Firm shall submit its determination and detailed supporting
calculations to both Iampietro and Unilife within fifteen (15) days after receipt of a notice from either Unilife or Iampietro that Iampietro may receive Payments If the Firm determines that none of the Total Payments, after taking into account
any reduction required by this Section 16, constitutes a “parachute payment” within the meaning of Code section 280G, it will, at the same time as it makes such determination, furnish Iampietro and Unilife an opinion that Iampietro
has substantial authority not to report any excise tax under Code section 4999 on his federal income tax return. 
 Iampietro and Unilife
shall each provide the Firm access to and copies of any books, records, and documents in the possession of Iampietro or Unilife, as the case may be, reasonably requested by the Firm, and otherwise cooperate with the Firm in connection with the
preparation and issuance of the determinations and calculations contemplated by this Section 16. The fees and expenses of the Firm for its services in connection with the determinations and calculations contemplated by this Section 16 shall be
borne by Unilife. 
 17. Counterparts. This agreement may be executed on separate counterparts, each of which is deemed to be an original and all of
which taken together constitute one and the same agreement. 
 18. Interpretation. The captions and headings of this agreement are not part of the
provisions hereof and shall have no force or effect. 
 19. Notices. Any notices, requests, demands and other communications provided for by this
agreement shall be sufficient if in writing and if hand delivered, sent by overnight courier, or sent by registered or certified mail to Iampietro at the last address he has filed in writing with Unilife or, in the case of Unilife, to Unilife’s
CEO at Unilife’s principal executive offices. 
 20. Governing Law. The terms of this agreement shall be governed by and construed in accordance with
the laws of the Commonwealth of Pennsylvania without giving effect to provisions thereof regarding conflict of laws. 
 21. Representations and
Warranties. Iampietro represents and warrants to Unilife that he is not bound by any restrictive covenants and has no prior or other obligations or commitments of any kind that would in any way prevent, restrict, hinder or interfere with
Iampietro’s acceptance of employment or the performance of all duties and services hereunder to the fullest extent of Iampietro’s ability and knowledge, except for the duty of confidentiality owed to former employers. If Iampietro has
misrepresented the representation and warranty provided herein, then Iampietro would be liable to Unilife for all damages incurred as a consequence thereof, including attorney’s fees and costs of court. 

[Remainder of the page left blank] 

  

					
		 	Page 12 of 13	  	

		 		  

 IN WITNESS WHEREOF, and wishing to be legally bound, the parties have executed this agreement as of the date
first above written. 
  

							
	UNILIFE CORPORATION:	 		 	Mark V. Iampietro:
				
	By:	 	

	 		 	
		 	  
	 		 	
		 	Alan D. Shortall	 		 	
		 	Chief Executive Officer	 		 	

  

					
		 	Page 13 of 13ex101.htm

The signing of this document will give rise to legal consequences.   Before signing it you are recommended to take independent legal advice.    MBM Commercial LLP act solely as agents for WD SPENCE PROSTHETICS LIMITED and for no other party.

 

SERVICE AGREEMENT

between

WD SPENCE PROSTHETICS LIMITED

and

HELEEN KIST

November 7, 2014

MBM Commercial LLP

Solicitors

EDINBURGH

 

  

1

  

AGREEMENT

between

 

WD Spence Prosthetics Limited, incorporated in Scotland (Company number SC307652) and having its registered office at c/o Centrum Offices, 38 Queen Street, Glasgow, G1 3DX (hereinafter called "the company")

 

and

 

HELEEN FRANCOISE KIST, residing at 48 Glencairn Drive, Glasgow, G41 4PR (hereinafter called "the executive")

 

WHEREAS the company carries on, inter alia, the business of providing healthcare services in the fields of Prosthetics, Orthotics, Rehabilitation, Diabetes and the company and the executive wish to record the terms and conditions upon which the executive will be employed by the company.

 

NOW IT IS HEREBY AGREED as follows:

 

1.             Definitions

 

	
1.1

	
In this Agreement and the Schedule annexed hereto:

 

“Associated Company” means any company which for the time being is a subsidiary or a holding company (as those expressions are defined by s.1159 of the Companies Act 2006) of the company or a subsidiary (other than the company) of any such holding company of the company and any company of which the equity share capital (as defined in s.548 of the Companies Act 2006) is owned as to 50 per cent or less but more than 25 per cent by such holding company or by any of its subsidiaries, or by the company or any of its subsidiaries as the case may be, and including a subsidiary of an associated company.

 

	
“the Board” means the Directors of the company.

 

	
“the Group” means the company and all Associated Companies from time to time.

 

	
1.2

	
In this agreement:

 

	
1.2.1

	
the provisions of the Interpretation Act 1978 with respect to interpretation and construction shall apply mutatis mutandis;

 

	
1.2.2

	
the singular includes the plural and the masculine includes the feminine and neuter and vice versa and references to a natural person include her or her estate and successors;

 

  

2

  

	
1.2.3

	
references to persons shall include bodies corporate, unincorporated associations and partnerships;

 

	
1.2.4

	
references to a statute include any modification, amendment or re-enactment of that statute;

 

	
1.2.5

	
references to recitals and clauses are, unless the contrary intention appears, references to the recitals and clauses of this agreement and the recitals form part of this agreement; and

 

	
1.2.6

	
the headings and sub-headings of this agreement are inserted for a convenience only and shall not affect the construction thereof.

 

2.             Term of appointment

 

	
2.1

	
The executive shall serve the company at 48 Glencairn Drive Glasgow G41 4PR or at such other address in the United Kingdom and/or abroad (on a temporary basis) as may be notified by the Board or to which the Board has consented in writing as Chief Operating Officer or in such other capacity as the company may require such other capacity not to be lower than the executive’s original appointment under this agreement. The executive’s employment shall be deemed to have commenced on October 1st , 2014 (notwithstanding the date or dates hereof) and shall continue until September 30th 2015 when it will automatically terminate or, if the parties agree that the employment should continue beyond September 30th 2014 until it is terminated in accordance with the provisions hereof. The executive will report to the Board.

 

	
2.2

	
The company may employ from time to time any other person or persons to act jointly with the executive in her employment with the company.

 

	
2.3

	
The company may at any time require the executive to serve any Associated Company, Associated Companies and/or any other company falling within the Group and to carry out for such Associated Company, Associated Companies and/or any other company falling within the Group such duties and responsibilities as may be assigned by the Board, but otherwise on the same terms and conditions as to salary and otherwise as herein provided.

 

	
2.4

	
If the executive gives notice under Clause 2.1 above the company may, in its sole discretion, give the executive a counter-notice terminating the executive’s employment.  Such counter-notice shall give the executive three months’ notice of termination of her employment.

 

	
2.5

	
Notwithstanding Clause 2.1 above, the company may during any period of notice or counter-notice require the executive to serve in some other capacity whether or not of like status provided that the executive shall continue to receive her salary and all other contractual benefits in terms of this agreement.

 

	
2.6

	
The company and any Associated Company to whom the executive may be assigned shall be under no obligation to provide any work, powers or duties for the executive during any period of notice whether given by the company or the executive or of any counter-notice given by the company to terminate the executive’s employment under this agreement. In the event that the company exercises this right, the executive will be required to comply with any conditions reasonably laid down by the company during such period of notice and during such time the executive will not be permitted to work for any other person, firm, client or corporation or on her own behalf without the company's prior written permission. The company may suspend the executive from her employment, exclude her from any or all of its premises and require her not to communicate with any employees/clients/prospective clients/suppliers or contractors of the company or Associated Company for the whole or any part of the applicable period of notice (or counter-notice) provided that during such suspension or exclusion the executive shall continue to receive salary and all other contractual benefits provided by this agreement.

 

  

3

  

	
2.7

	
Subject to the overriding provisions of Clause 16.1 below, the company shall have the right to terminate the executive’s employment immediately on payment to the executive of pay in lieu of notice (or the balance of any notice period) under Clause 2.1 or counter notice under Clause 2.4 above.

 

	
3.

	
Duration of employment

 

	 	
The duration of this contract is one (1) year, starting on October 1st, 2014 and ending on September 30th, 2015 (except where any of the other provisions of this agreement apply including but not limited to Clause 16 in which case the contract can be terminated prior to September 30th 2014), when it will terminate automatically without any further notice being given.  Should the executive and the company agree that the employment should continue beyond September 30th 2015, it shall do so under the terms of this Agreement, and shall continue until either party serves three months’ notice in writing or until it is otherwise terminated in accordance with this agreement.

 

	
4.

	
Description of job

 

The executive will be employed as Chief Operating Office (“COO”) of the company.  The COO will oversee all operations for the HCi Viocare group of companies, to which the company belongs, help develop the strategy for the business and engage in commercial negotiations with potential partners and carry out all other duties expected of a COO as directed by the Board.  She

 

5.             Freedom to take up the appointment

 

	 	
The executive warrants that she is free to take up employment with the company and that by virtue of entering into this agreement she will not be in breach of any express or implied terms of any contract or of any other obligation binding upon her. The executive further confirms that by virtue of entering into this agreement she is not or will not be in breach of any other contract of employment or consultancy agreement (past or now subsisting) or be liable to any action (whether for damages, injunction, interdict, specific performance, specific implement or otherwise) relating to any such contract or agreement or be in any breach of duty of confidence or any undertaking or arrangement relating to any rights to Intellectual Property (as hereinafter defined) or be liable to any action (whether for damages, injunction, interdict, specific performance, specific implement or otherwise) relating to any continuous or continuing obligations in connection with any such contract or agreement and to the extent that the executive is not so free to take up employment with the company or is or will be so in breach or is so liable, then this shall be a material breach of this agreement entitling the company to summarily terminate this agreement forthwith pursuant to Clause 16.1 below.

 

6.             Powers and duties

 

	
6.1

	
During her employment hereunder the executive shall faithfully and diligently exercise such powers and perform such duties in relation to the business of the company or any Associated Company as may from time to time be vested in or assigned to her by the Board and shall comply with all reasonable directions and instructions from time to time given to her by the Board. The executive will be subject to regular performance reviews by the company.

 

	
6.2

	
During the continuance of her employment under this agreement the executive:-

 

	
6.2.1

	
shall during the normal working hours specified in the Schedule hereto (unless prevented by ill health and except during holidays permitted by this agreement) devote substantially the whole of her time, attention, skill and abilities to carrying out her duties hereunder;

 

	
6.2.2

	
shall conform to such hours of work as may from time to time reasonably be required of her and shall not be entitled to receive any additional remuneration for work performed outside her normal working hours specified in the Schedule hereto;

 

  

4

  

	
6.2.3

	
in pursuance of her duties hereunder, shall perform such services for any Associated Company within the United Kingdom and (without further remuneration unless otherwise agreed) accept such offices within the United Kingdom as the Board may from time to time reasonably require;

 

	
6.2.4

	
shall travel to such places (whether in or outside the United Kingdom) and in such manner and on such occasions as the Board may from time to time reasonably require;

 

	
6.2.5

	
shall carry out her duties in a proper, loyal and efficient manner and shall use all reasonable endeavours to promote the interests and reputation of the company and its Associated Companies and not do anything which is harmful to them;

 

	
6.2.6

	
co-operate with any person or persons appointed by the company to act jointly with the executive in discharging her duties in terms of this agreement;

 

	
6.2.7

	
at all times keep the Board and, if applicable, the board of any Associated Company, Associated Companies and/or any other company falling within the Group promptly and fully informed (in writing if so requested) of her conduct of the business or affairs of the company, any Associated Company, Associated Companies and/or any other company falling within the Group, for which she is required to perform duties and provide such other information, written records or explanations as the Board, any Associated Company, Associated Companies and/or any other company falling within the Group may require;

 

	
6.2.8

	
shall not at any time make any untrue or misleading statement in relation to the company or any Associated Company;

 

	
6.2.9

	
shall comply, and shall so far as it lies within her power and area of responsibility, procure compliance by the company or any other Associated Company, with:

	
-

 

	
(a)

	
every rule of law; and

 

	
(b)

	
the provisions of the Rules of and the Combined Code of Conduct issued by the Financial Reporting Council (or any successor) and all other applicable statutory and other regulatory requirements for the time being in force concerning the business of the company or any other Associated Company and the performance by the executive of her duties hereunder.

 

7.             Intellectual property rights

 

	
7.1

	
For the purposes of this agreement:-

 

	
(a)

	
“Intellectual Property” shall mean all copyrights, database rights, design rights (registered and unregistered), topography rights, trade marks, trade secrets, know-how, inventions, patents and other intellectual property rights of any nature (whether registered or unregistered) and all rights therein and applications therefor in any part of the world including but not limited to the right to make applications.

 

	
(b)

	
“Works” shall mean works or materials of any nature including but not limited to artwork, text, reports, specifications, drawings, technical information, designs, plans, inventions, products, prototypes, tests, tools, discoveries, secret processes or improvements in procedures, techniques, methodologies, systems, equipment or services.

 

  

5

  

	
7.2

	
Without prejudice to the company’s rights in relation to Intellectual Property by law as the employer of the executive, the executive hereby acknowledges and agrees that:

 

	
(a)

	
all Intellectual Property in all Works written, originated, developed, improved upon, conceived, discovered or made by the executive:-

 

	
(i)

	
in the course of her employment;

 

	
(ii)

	
in connection with or in any way affecting or relating to any of the businesses of the company; and/or

 

	
(iii)

	
capable of being used or adapted for use therein or in connection therewith, shall forthwith be disclosed by the executive to the company and shall belong to and vest in the company or such third party as the Board may deem appropriate from the date of creation of the same. These provisions are subject always to the executive’s statutory rights as inventor. 

 

	
(b)

	
insofar as not effected by virtue of the executive’s employment with the company, the executive hereby assigns to the company by way of future assignation all such Intellectual Property and all proprietary rights thereto for the full term thereof throughout the world in respect of such Works insofar as such future assignation is competent.

 

	
(c)

	
The executive hereby waives any and all moral rights (as defined in terms of ss.77 and 80 of the Copyright, Designs and Patents Act 1988) she may have in respect of such Works.

 

	
(d)

	
The executive acknowledges that due to her senior role in the company, she has a special duty and responsibility to further the interests of the company and that she is employed in an inventive and creative capacity due to the nature of her job.

 

	
7.3

	
The executive shall promptly and from time to time, both during her employment hereunder and thereafter at the request and expense of the company, give and supply all Works and/or information, data, drawings and assistance as may be requisite to enable the company to exploit such rights to Intellectual Property to the best advantage and shall do all such things and apply for and execute all applications and documents as may in the sole opinion of the Board be necessary for or conducive to giving effect to the purposes of this Clause 7, obtaining patents, registered designs or other intellectual property protection in any part of the world in respect of the Intellectual Property referred to in this Clause 7 and/or to protect and defend the same and, where applicable, to vest the entire right, title and interest to the same in the company or such third party as the Board may deem appropriate. For the avoidance of doubt, the discretion as to whether or not to apply for patent, trade mark or design registration or other similar protection shall be solely for the company. The company reserves the right to regard any such rights of Intellectual Property as Confidential Information in which event the executive shall observe the obligations that relate to Confidential Information contained in Clause 9 below.

 

	
7.4

	
The executive shall not knowingly do anything to imperil the validity of any such protection or any application therefor or to prejudice any such Intellectual Property in any respect but on the contrary shall at the reasonable cost of the company or such third party, as the case may be, render all possible assistance to the company or such third party both in obtaining and maintaining such protection.

 

	
7.5

	
The executive undertakes not to seek to develop or commercially exploit any Intellectual Property other than through the company during her employment with the company.

 

  

6

  

	
7.6

	
The executive irrevocably appoints the company to be the executive’s agent in the executive’s name and on the executive’s behalf to execute any instrument or document and generally to use the executive’s name for the purpose of giving to the company the full benefit of the provisions of this clause. A certificate in writing signed by any director or secretary of the company that any instrument, document or act falls within the authority hereby conferred shall be conclusive evidence that such is the case.

 

	
7.7

	
For the avoidance of avoid any doubt, the executive shall not be entitled to use any Intellectual Property of the company after the expiry or termination of her employment.

 

	
7.8

	
All rights of Intellectual Property created as a result of the executive's service under this agreement shall be treated in all respects as if the company were its author and first owner for the purposes of ss.9(2) and 11(2) of the Copyright, Designs and Patents Act 1988.

 

	
7.9

	
If any of the rights to Intellectual Property created as a result of the executive’s service under this agreement are not the property of the company, the company shall, subject to the provisions of the Patents Act 1977, the Registered Designs Act 1949 and the Copyright, Designs and Patents Act 1988, have the right to acquire for itself or its nominee the executive's rights in the Intellectual Property within 3 months after disclosure pursuant to this clause on fair and reasonable terms to be agreed, or as settled by a single arbiter.

 

	
7.10

	
The provisions of this Clause 7 shall not entitle the executive to any compensation.

 

	
7.11

	
Rights and obligations under this Clause 7 shall continue in full force and effect after termination of the executive’s employment with the company in respect of the Intellectual Property created during the executive's employment with the company and shall be binding upon the executive's representatives, heirs and assignees.

 

8.             Non-competition during employment

 

	
8.1

	
The executive shall disclose to the company any interest of her own or that of any member of her family including e.g. parents/children/siblings, etc. in any trade, business or occupation whatsoever which is in any way similar to any of those in which the company is involved whether or not such trade, business or occupation may be conducted for profit or gain.

 

	
8.2

	
The executive shall not at any time while employed by the company, without the prior written consent of the company, either solely or jointly or in partnership or association with or as director, shareholder, manager, agent, principal, adviser, employee or representative of or for any other person, firm or company or by way of joint venture, directly or indirectly carry on or be engaged or concerned or interested in any business that may cause a conflict of interest with the company.

 

	
8.3

	
Nothing in Sub-Clauses 8.1 or 8.2 of this clause shall preclude the executive from holding any shares or loan capital for the time being issued in any company whose shares are listed or dealt in on a recognised stock exchange, provided that the executive (together with her spouse and minor children) does not at any time hold, nor is at any time beneficially interested in more than a total of three per cent of the issued securities of that class.

 

  

7

  

9.             Confidential information

 

	
9.1

	
Confidential information and trade secrets relating to the business of the company any Associated Company, Associated Companies and/or any other company falling within the Group and its customers, whether or not the executive dealt with them shall include but is not limited to information relating to:-

 

	
9.1.1

	
any and all contractual arrangements entered into between the company any Associated Company, Associated Companies and/or any other company falling within the Group and any customer, particularly with regard to fees;

 

	
9.1.2

	
any information held on database;

 

	
9.1.3

	
the company’s fee structure;

 

	
9.1.4

	
the company’s corporate and marketing strategy, business development and plans, sales reports, product surveys and research results;

 

	
9.1.5

	
business methods and processes, compliance and procedural manuals, technical instructions, information and know-how relating to the Group’s business and which is not available to the public generally, including inventions, designs, programs, techniques, database systems, formulae and ideas, and other rights of the company to the Intellectual Property;

 

	
9.1.6

	
business contact details of suppliers, potential suppliers, customers and potential customers, lists of customers, suppliers and employees, and details of contracts with the company any Associated Company, Associated Companies and/or any other company falling within the Group, including the company’s insurance requirements and insurance rates;

 

	
9.1.7

	
the company’s budgets, management accounts, trading statements and other financial reports; and

 

	
9.1.8

	
any document marked “confidential”, all of which are collectively referred to in this agreement as the “Confidential Information”.

 

  

8

  

	
9.2

	
Without prejudice to the executive’s duty at common law to protect the Confidential Information of the company, the executive shall not either during her employment by the company or thereafter, except in the proper execution of her duties hereunder or unless ordered to do so by a court of competent jurisdiction (or otherwise as may be required by law), directly or indirectly:-

 

	
(a)

	
divulge or communicate to any person (including, without limitation, any representative of the press or broadcasting or other media);

 

	
(b)

	
cause, through any failure by her to exercise all due care and diligence, any unauthorised disclosure of; or

 

	
(c)

	
make use of, other than for the benefit of the company any Associated Company, Associated Companies and/or any other company falling within the Group, any information of the company any Associated Company, Associated Companies and/or any other company falling within the Group which the executive knows or ought reasonably to know the company any Associated Company, Associated Companies and/or any other company falling within the Group regards as Confidential Information (whether or not designated as confidential) and all such information concerning the organisation, business finances, transactions and affairs of the company any Associated Company, Associated Companies and/or any other company falling within the Group and of their respective suppliers, customers and contractors which she may have received or obtained while in the service of the company any Associated Company, Associated Companies and/or any other company falling within the Group.

 

	
9.3

	
The executive shall use her best endeavours to prevent the publication or disclosure of such Confidential Information by any party both during her employment by the company and thereafter.

 

	
9.4

	
The provisions of this clause shall apply mutatis mutandis in relation to the confidential or secret information of each Associated Company which the executive may have received or obtained during her employment by the company and the executive shall at the request and expense of the company promptly undertake in writing with any such Associated Company to the like effect.

 

	
9.5

	
The provisions of confidentiality in this Clause 9 shall apply after termination of the employment of the executive and shall apply without limit in point of time.

 

	
9.6

	
All notes, memoranda, records and other copyright material, including those stored on computer software, which are made by the executive during the executive’s employment and relating to the business of the company, any Associated Company, Associated Companies and/or any other company falling within the Group shall from the date of creation belong to the company any Associated Company, Associated Companies and/or any other company falling within the Group and shall promptly be handed over to the company any Associated Company, Associated Companies and/or any other company falling within the Group, or as the company directs, from time to time.

 

	
9.7

	
The above obligations of the executive shall cease to apply to information or knowledge which has (otherwise than in breach of an obligation of confidence) come into the public domain.

 

	
9.8

	
The executive agrees that she shall, at the request of the company any Associated Company, Associated Companies and/or any other company falling within the Group, enter into a direct agreement or undertaking with any company falling within the Group in respect of which the executive has, in the performance of her duties under this agreement or by reason of services rendered to or offices held by her in any such company, received Confidential Information of such company whereby she shall accept restrictions and provisions corresponding to (or, to the extent that they do not so correspond, which are not more onerous on the executive than) the provisions contained in this Clause 9.

 

  

9

  

10.             Return of papers, etc.

 

	 	
The executive shall promptly whenever requested by the company and in any event upon the termination of her employment with the company deliver up to the company all property whatsoever belonging to the company or any Associated Company including, without limitation e.g. all Intellectual Property, all correspondence/keys/security passes/credit cards/designs/statistics/computer disks/books/tapes or other storage media etc. and all other papers, documents and records whatsoever which may have been prepared by her or have come into her possession or control in the course of her employment with the company any Associated Company, Associated Companies and/or any other company falling within the Group and the executive shall not be entitled to and shall not retain any copies thereof. Title and copyright therein shall vest in the company. The executive will, on being requested to do so, and in any event within seven days of a request therefor, send to the company any Associated Company, Associated Companies and/or any other company falling within the Group a signed statement that she has complied with this obligation.

 

11.             Remuneration

 

	
11.1

	
The executive shall be paid by way of remuneration for her services during her employment hereunder a salary at the rate of £30,000 (gross) per annum. The said salary will be reviewed by the Board at the end of the first year (October 7th, 2015) of this employment (provided it is agreed between the parties that the executive’s employment will continue beyond September 30th 2015), with a view to bringing it in line with market value, subject to the company having sufficient funding.The executive’s remuneration will then be reviewed by the board annually thereafter.  The company shall be under no obligation to increase the remuneration.   The executive’s salary shall accrue from day to day and shall be paid monthly in arrears on or around the last Friday of every month by credit transfer to the executive’s nominated bank account, less deductions for PAYE, National Insurance contributions and any statutory, agreed or other deductions which the company is required to make.

 

	
11.2

	
Notwithstanding anything to the contrary contained in the articles of association of the company or any Associated Company the executive shall not be entitled to any other remuneration either as an ordinary or executive director or employee of the company or any Associated Company and the executive shall as the company may direct either effectually waive any right to any such remuneration or shall account for and pay over the same to the company immediately she receives it.

 

12.             Sickness

 

	
12.1

	
In the event of absence on account of sickness or injury the executive (or someone on her behalf) must inform the company of the reason for the executive’s absence as soon as possible and must do so no later than 10.00 am on the first day of absence. In respect of absence lasting up to seven calendar days (including Saturdays and Sundays) the executive is not required to produce a medical certificate unless specifically so requested by the company but must complete a self-certification form (stating the dates of and the reason for the absence, including details of sickness on non-working days) on return to work from such absence. The executive should also leave details of how and where she can be contacted during the period of such absence.

 

	
12.2

	
In respect of absence lasting more than seven calendar days the executive must on the eighth calendar day of absence provide the company with a medical certificate stating the reason(s) for absence and thereafter provide further certificate(s) to cover any subsequent period of absence on a monthly basis. The company reserves the right to ask the executive at any stage of absence to produce additional medical certificate(s) and/or to undergo a medical examination at the cost of the company.

 

	
12.3

	
Without prejudice to the terms of Clause 12.2, at the request and expense of the company, the executive shall submit annually to a medical examination by a medical practitioner nominated by the company as part of a health screening programme and for insurance purposes and the executive shall authorise such medical practitioner to disclose to or discuss with the company's medical adviser any matters arising from such examination, and the company's medical adviser may notify the company of any serious matter if, in his or her opinion, it might materially or adversely affect the health of the executive or the proper discharge of her duties.

 

	
12.4

	
If the sickness of the executive shall result in the aggregate period of absence exceeding 183 working days in any period of 12 consecutive months, then the company shall be entitled to terminate the employment of the executive by giving not less than 14 days’ notice in writing to the executive and the executive shall not be entitled to claim any compensation from the company in respect of such termination and the executive, by her execution of this agreement, waives any statutory or other rights to: (i) any other period of notice of termination; (ii) payment in lieu of notice; and (iii) compensation in respect of such termination.

 

  

10

  

	
12.5

	
If the sickness of the executive shall result in the aggregate period of absence exceeding 183 working days in any period of 12 consecutive months, then, the company may give notice in writing to the executive at any time thereafter, but while the sickness of the executive continues, to the effect that:-

 

	
12.5.1

	
the executive shall, while the sickness continues, have no further entitlement to receive a basic salary in terms of Clause 11.1; and

 

	
12.5.2

	
the executive is required to resign from all offices held by her in the company any Associated Company, Associated Companies and/or any other company falling within the Group, provided that:-

 

	
12.5.2.1

	
if the executive shall fail to resign from any such office within 30 days after the service of such notice, she may be removed from such office, but her failure to resign shall not constitute a breach of her obligations under this agreement; and

 

	
12.5.2.2

	
notwithstanding her resignation or removal from all such offices, the executive shall continue to be employed by the company on the terms set out in this agreement (as modified by the provisions of this sub-Clause 12.5) and this agreement shall, in all other respects, remain in full force and effect.

 

For the avoidance of doubt, it is hereby stipulated that the executive’s continuing inability to perform her duties and obligations in terms of this agreement by reason of sickness shall not operate to frustrate or terminate this agreement.

 

13.             Sick pay

 

	
13.1

	
The company will pay to the executive her normal basic remuneration (less the amount of any statutory sick pay or incapacity benefit to which she may be entitled) for a period or periods of absence not exceeding fourteen days during which she is wholly incapable of performing her duties due to sickness or injury. Any payment of remuneration after this period shall be at the sole discretion of the company.

 

	
13.2

	
The company shall be entitled to deduct from the executive’s salary the amount of income or other benefits which she is entitled to claim in consequence of the executive’s sickness under the national insurance scheme for the time being in force, any scheme for the time being in force of which the executive is a non-contributing member and any other similar scheme or arrangement (whether or not such benefits are received). Nothing in this clause affects the executive’s entitlement to Statutory Sick Pay but any sick pay entitlement payable pursuant to this Clause 13 shall be inclusive of the executive’s Statutory Sick Pay entitlement.

 

	
13.3

	
In the event that the executive is incapable of performing her duties by reason of injury sustained wholly or partially as a result of actionable negligence, nuisance or breach of any statutory duty on the part of any person other than the parties hereto (the “Third Party”), all payments made to the executive by the company under Sub-Clause 12.1 shall, to the extent that compensation is recoverable from the Third Party, and subject to compliance with the provisions of ss.197 to 214 (inclusive) of the Companies Act 2006, constitute loans by the company to the executive (notwithstanding that, as an interim measure, income tax may have been deducted from such payments as if they were emoluments of employment) and shall be repaid to the company when and to the extent that the executive recovers compensation for loss of earnings from the Third Party by action or otherwise.

 

	
13.4

	
Entitlement to payment is subject to notification of absence and production of medical certificates in accordance with Clause 12 above.

 

 

  

11

  

14. Holidays

 

	
14.1

	
The executive shall be entitled to 29 working days holiday (inclusive of 8 days of public holidays)with pay in each holiday year or a pro-rata portion of this if the executive is part time (e.g. 23 holidays per year if the executive works four days a week). Holidays may only be taken at times agreed two months in advance with the Board (unless otherwise agreed) and for the avoidance of doubt, the executive is not allowed to take more than two weeks’ holiday at any one time. The executive may be required to work any public holiday subject to receiving a day off.

 

	
14.2

	
If the executive’s employment commences or terminates part way through the holiday year her entitlement to holidays during that year will be assessed on a pro rata basis and deductions from final salary due to the executive on termination of employment will be made in respect of holidays taken in excess of entitlement.

 

	
14.3

	
The company’s holiday year runs from 1st January to 31st December.

 

	
14.4

	
Holidays not taken in the holiday year to which they relate will be lost and cannot be carried forward from one year to the next, unless permission is granted in advance by the Board.

 

15.             Expenses

 

	
15.1

	
The company shall reimburse to the executive all reasonable e.g. travelling/hotel/entertainment, etc. and other out-of-pocket expenses properly incurred by her in the execution of her duties hereunder and as per company’s instructions on production of vouchers or other reasonable evidence of actual payment of the said expenses.

 

16.             Termination of employment

 

	
16.1

	
If the executive:

 

	
16.1.1

	
shall be or become of unsound mind or be or become a patient for any purpose of any statute (or any part thereof) relating to mental health or otherwise incapax;

 

	
16.1.2

	
is or becomes insolvent or apparently insolvent, bankrupt or compounds with her creditors or grants a trust deed for behoof of her creditors (or their respective equivalents in any other jurisdiction);

 

	
16.1.3

	
is or becomes prohibited by law from being a director of the company or if she shall for any reason cease to be a director of the company; or

 

	
16.1.4

	
shall be guilty of serious misconduct or shall have neglected or failed to carry out, or refused to attend to, or shall have committed any serious, wilful or persistent breach, non-observance or non-performance of any of her obligations or duties to the company or any Associated Company (whether under this agreement or otherwise) or if she shall refuse or neglect to comply with any lawful orders or directions given to her by the company;

 

  

12

  

	
16.1.5

	
is convicted of any arrestable criminal offence (other than an offence under road traffic legislation in the United Kingdom or elsewhere for which a fine or non-custodial penalty is imposed);

 

	
16.1.6

	
resigns as a director of the company or any Associated Company otherwise than at the request of the company or such Associated Company;

 

	
16.1.7

	
in the opinion of the Board or Officer, shall have repeated or continued any breach, non-observance or non-performance of her duties or obligations under this agreement (insofar as such breach or non-observance does not fall within Clause 16.1.4) after she has received a written warning from the company regarding such breach or non-observance or non-performance;

 

	
16.1.8

	
shall have been guilty of any conduct which, in the opinion of the Board, has brought or could bring her, the company or the Group into disrepute or has prejudiced or could prejudice the business or affairs of the company or the Group;

 

	
16.1.9

	
shall have committed any act of dishonesty or any breach of a fiduciary duty whether relating to the company, the Group or otherwise involving personal profit, the company shall be entitled by notice in writing to the executive to determine forthwith her employment under this agreement whereupon the executive shall not be entitled to receive any pay in lieu of notice in terms of Clause 2.7 above (and in which event, Clause 2.7 shall have no effect) and shall have no claim against the company for damages or otherwise by reason of such determination except for such sums as shall have accrued due at the date of termination of the employment of the executive.

 

	
16.2

	
On the termination of the employment (howsoever caused) of the executive or if the company suspends or excludes the executive under Clauses 2.6 or 16.3, the executive shall, at the request of the company and without claim for compensation, the executive shall forthwith resign her office as a director of the company and any Associated Company of which she is a director and at the request of the company and without claim for compensation, shall forthwith resign, without claim for compensation, from all other appointments or offices which she holds as nominee or representative of the company or any Associated Company and shall transfer to the company or any Associated Company as appropriate without payment any qualifying or nominee shares that she holds on behalf of the company or the Associated Company and in the event of her failure to do so, the company is hereby irrevocably authorised to appoint some person in her name and on her behalf to sign and deliver such resignations and transfers to the Board.

 

	
16.3

	
If the company has any grounds to believe that it may have a right to determine forthwith the employment of the executive in terms of Clause 16.1 above, it shall be entitled (but without prejudice to its right subsequently to terminate the employment of the executive on the same or any other ground) to suspend the executive on full pay during the period of any enquiry or investigation into the circumstances giving rise to such belief.

 

	
16.4

	
The executive shall not after the termination of her employment hereunder, howsoever caused, represent herself as being employed by or connected with the company or any Associated Company.

 

	
16.5

	
Any delay or forbearance by the company in exercising any right under this clause shall not constitute a waiver of it.

 

  

13

  

17.             Misrepresentation

 

	
17.1

	
The executive shall not after the determination of her employment hereunder wrongfully represent herself as being employed by or connected with the company or any Associated Company.

 

18.             Restrictions

 

	
18.1

	
Whereas the company is engaged in the provision of sponsorship, marketing and communication consultancy  which business of the company is national in nature, and in particular involves consultancy services to clients in the United Kingdom and whereas the company (and, if relevant, any Associated Company in the Group) has a legitimate interest in protecting its goodwill, business connections and customer base and in maintaining a suitable and well trained workforce, therefore the executive agrees, in order to safeguard the Confidential Information, trade secrets and goodwill of the company and each of the companies in the Group to be bound by these covenants whereby the executive will not within the United Kingdom and without the prior written consent of the company (such consent only to be withheld so far as may reasonably be necessary to protect the legitimate business interests of the company) whether alone or jointly with or as shareholder, adviser, principal, partner, agent, director, employee, consultant or otherwise, directly or indirectly:-

 

	
18.1.1

	
for the period of two years after the Termination Date entice, solicit or canvass, or attempt to entice, solicit or canvass, away from the company (and, if relevant, any Associated Company of the Group) the business or custom of any person, company or other undertaking who or which is or has been a customer or client of the company  (and, if relevant, any Associated Company of the Group) and with whom the executive has had contact, conducted negotiations on behalf of the company or dealt with at any time during the twelve months immediately prior to the Termination Date in the performance of her duties under this Agreement or by any reason of services rendered to or offices held by her in the company  (and, if relevant, any Associated Company of the Group) (the “Customers”), provided that such enticement, solicitation, canvassing or attempts at the same, can reasonably be expected to have a detrimental effect on the company's  (and, if relevant, any Associated Company of the Group) legitimate business interests generally in protecting its business connections, goodwill and customer base, and further provided that this restriction shall not prohibit the executive from enticing, soliciting or canvassing, or attempting to entice, solicit or canvass, away from the company the business or custom of any of the Customers which is not in direct or indirect competition with any business or custom carried on, conducted or undertaken by the company  (and, if relevant, any Associated Company of the Group) in the ordinary course of business prior to the Termination Date;

 

	
18.1.2

	
for the period of two years after the Termination Date, deal with or accept instructions or business from any person, company or other undertaking who or which is or has been a customer or client of the company  (and, if relevant, any Associated Company of the Group) and with whom the executive has had contact, conducted negotiations on behalf of the company or dealt with at any time during the twelve months immediately prior to the Termination Date in the performance of her duties under this Agreement or by any reason of services rendered to or offices held by her in the company  (and, if relevant, any Associated Company of the Group) (the “Customers”), provided that such dealings or acceptance of instructions or business from any of the Customers can reasonably be expected to have a detrimental effect on the company's  (and, if relevant, any Associated Company of the Group) legitimate business interests generally in protecting its business connections, goodwill and customer base, and further provided that this restriction shall not prohibit the executive from dealing with or accepting instructions or business from any of the Customers in respect of any business which is not in direct or indirect competition with any business or custom carried on, conducted or undertaken by the company  (and, if relevant, any Associated Company of the Group) in the ordinary course of business prior to the Termination Date;

 

  

14

  

	
18.1.3

	
for the period of two years after the Termination Date, carry on or be engaged, employed, concerned or interested, whether for her own account or otherwise, in any business carried on, or about to be carried on, by any person, company or other undertaking in the United Kingdom which is, or is likely to be, competitive with any business carried on by the company  (and, if relevant, any Associated Company of the Group) in the field of Prosthetics, Orthotics, Rehabilitation and Diabetes as at the Termination Date, or hold a controlling shareholding position in the same, provided that such engagement, employment, concern or interest can reasonably be expected to have a detrimental effect on the company's  (and, if relevant, any Associated Company of the Group) legitimate business interests generally in protecting their business connections, goodwill and customer base and further provided that this restriction shall not prohibit the executive from being engaged, employed, concerned or interested, whether for her own account or otherwise, in any business, company or other undertaking in so far as her involvement therein or duties in connection therewith shall relate exclusively to work of a kind or nature with which the company  (and, if relevant, any Associated Company of the Group) was not concerned to a material extent during the twelve months immediately prior to the Termination Date;

 

	
18.1.4

	
for the period of two years after the Termination Date, hire, engage, employ, solicit or canvass, or attempt to solicit or canvass, or endeavour to entice or induce or encourage away from the employment of the company  (and, if relevant, any Associated Company of the Group) for the purpose of being involved in or concerned with a competing business of the company (and, if relevant, any Associated Company of the Group)any person who shall have been a senior employee (including, without limitation, any director or employee in a senior management position, and/or any senior employee with specialist or technical know-how) of the company  (and, if relevant, any Associated Company of the Group) immediately prior to the Termination Date and who is and who was engaged in an area of business the same or substantially similar to that in which the executive was engaged at any time during the twelve months immediately prior to the Termination Date and with whom the executive had dealt or had contact in the performance of her duties under this Agreement or by reason of services rendered to or offices held by her regardless of whether such senior employee acts in breach of her or her contract of employment with the company  (and, if relevant, any Associated Company of the Group) by doing so, provided that such hiring, engagement, employment, solicitation, canvassing, attempts at the same, enticement, inducement or encouragement of the said senior employees can reasonably be expected to have a detrimental effect on the company’s  (and, if relevant, any Associated Company of the Group) legitimate business interests in maintaining a stable and well trained workforce;

 

	
18.1.5

	
for the period of two years after the Termination Date, interfere, or seek to interfere, with: (a) the supply to the company  (and, if relevant, any Associated Company of the Group) of any goods or service by any supplier who, during the  twelve months immediately prior to the Termination Date, shall have supplied goods or services to the company  (and, if relevant, any Associated Company of the Group) or (b) the terms on which such supply was made during such period of twelve months.

 

	
18.2

	
The executive acknowledges and agrees that each of the sub-clauses above constitutes an entirely separate and independent restriction on her and that the duration, extent and application of each of such restrictions are no greater than is necessary for the protection of the legitimate interests of the company (and, if relevant, any Associated Company of the Group) for which she is required to perform duties.

 

	
18.3

	
Whilst each of the restrictions contained in Sub-Clause 18.1 are considered by the parties to be reasonable in all the circumstances as at the date of this agreement, if any one or more of such restrictions shall be judged to be void as going beyond what is reasonable in all the circumstances for the protection of the legitimate business interests of the company (and, if relevant, any Associated Company of the Group), but would be valid if any one or more of the period of the restriction, the range of activities, and the area to which the restriction relates were reduced, the restriction(s) shall be deemed to apply with such modification(s) as may be necessary to make them valid and effective and any such modification of one restriction shall not affect the validity of any other restriction contained in this agreement.

 

  

15

  

	
18.4

	
The restrictions contained in this Clause 18 will not prevent the executive from directly or indirectly owning shares for bona fide investment purposes in any company which is listed or dealt in on any recognised investment exchange.

 

	
18.5

	
By her signature of this agreement, the executive agrees and acknowledges that she will bring the terms of Clause 18.1 of this agreement to the attention of her future employers after the Termination Date.

 

19.             Continuation of agreement

 

	
19.1

	
The expiration or termination of this agreement (howsoever caused) shall:-

 

	
19.1.1

	
not operate to affect such of the provisions of this agreement which are expressed to operate or have effect thereafter (including, without prejudice to the foregoing generality, Clauses 7, 9, 16 and/or 18); and

 

	
19.1.2

	
be without prejudice to: (a) any right of action which has accrued to either of the parties hereto at the time of such expiration or termination; or (b) any right of action by either of the parties hereto in respect of any breach of this agreement by the other party hereto (whether such breach occurs prior to or subsequent to such expiration or termination).

 

20.             Notices

 

	
20.1

	
Any notice in writing to be served hereunder may be given personally to the executive or to the secretary of the company (as the case may be) or may be posted to the company (for the attention of its secretary) at its registered office for the time being or to the executive either at her address given above or at her last known address. Any such notice sent by post shall be deemed served twenty-four hours after it is posted and in proving such service it shall be sufficient to prove that the notice was properly addressed and put in the post.

 

21.             The Schedule

 

	
21.1

	
The provisions set out in the Schedule annexed hereto as from time to time altered, added to or abrogated are incorporated into this agreement. The company may from time to time notify the executive in writing that it proposes to alter, add to or abrogate any provisions of the Schedule giving details of the changes. Unless the executive shall within 14 days of such notice notify the company in writing that she objects to those changes, such alteration, addition or abrogation shall be deemed to be agreed and shall take effect accordingly. For the avoidance of doubt, in accordance with the provisions of ss.7A and 7B of the Employment Rights Act 1996, the terms and conditions contained within this agreement and the Schedule annexed hereto shall constitute and contain all of the requisite written statement of terms and conditions in terms of Pt I of the Employment Rights Act 1996.

 

  

16

  

22.             Entire contract and variation

 

	
22.1

	
This contract contains the entire and only agreement between the parties, and both parties acknowledge that, on entering into this contract, they have not relied on any written or oral representation or undertaking other than as expressly stated in this contract, and that this contract supersedes any previous contract or arrangement between the parties.

 

	
22.2

	
No variation of this contract shall be effective unless it is in writing and is signed by or on behalf of both parties.

 

23.             Governing law

 

	
23.1

	
This Agreement shall be governed by and construed under the law of Scotland and the parties hereby prorogate the non-exclusive jurisdiction of the Scottish Courts; IN WITNESS WHEREOF these presents consisting of this and the Sixteen preceding pages together with the Schedule annexed hereto are executed as follows:

 

  

17

  

 

SUBSCRIBED for and on behalf of the said WD SPENCE PROSTHETICS LIMITED by DR CHRISTOS KAPATOS, one of its Directors at Glasgow on the   [    ]                  day of [         ] Two thousand and fourteen before this witness

Witness                      .......................................                                                                            ........................................

           Dr Christos Kapatos

Full name                      .......................................

Address                      .......................................

.......................................

SUBSCRIBED by the said HELEEN FRANCOISE KIST at Glasgow on the   [     ]day of [       ]Two thousand and fourteen before this witness

Witness                      .......................................                                                                           ........................................

           Heleen Françoise Kist

Full name                      .......................................

Address                      .......................................

.......................................

  

18

  

SCHEDULE

 

This is the Schedule referred to in the foregoing agreement between WD Spence Prosthetics Limited and Heleen Françoise Kist dated [     ] 2014

 

1.             Grievance procedure

In the event of the executive wishing to seek redress of any grievance relating to her employment she should refer to the company’s grievance procedure and policy.

 

2.             Place of work

The executive’s normal place of work is 48 Glencairn Drive Glasgow G41 4PR until such time that the company has established permanent offices in Glasgow however the Board shall be entitled to require the executive to work at such other places within the United Kingdom and/or abroad on a temporary basis as the company shall from time to time direct.

 

3.             Continuous employment

The executive’s employment with the company began on October 1st, 2014.

 

4.             Disciplinary rules

The disciplinary rules are referred to in the Appendix to this Agreement and form part of your contract of employment with the company.

5.           Normal working hours

9am to 5pm from Monday to Thursday, or other equivalent of 4 working days per week during weekdays at the discretion of the executive with regard to the needs of the company

  

19

  

APPENDIX

Disciplinary procedure and Grievance procedure

1.           General

	
(A)

	
Without prejudice to the employer’s general right to terminate the contract by giving the notice required by Clause C hereof, the Disciplinary Procedure will be applied in all cases of alleged misconduct, incompetence or inadequate performance of work.

	
(B)

	
The executive is expected to perform her or her duties with reasonable efficiency and diligence, to behave towards fellow employees and outside parties with courtesy and decorum and not to misuse, or damage, or mis-appropriate the Employer’s property.

	
(C)

	
The company reserves the right of summary dismissal without salary in lieu of notice in cases of gross and wilful misconduct or gross neglect of duties.

	
(D)

	
Minor misconduct or breaches of rules will normally be dealt with by the Board, in the first instance.  However, should the executive fail to meet any requirements indicated for future behaviour, the formal disciplinary procedure will be actioned.

2.           Formal Disciplinary Procedure

	
(A)

	
The formal disciplinary procedure will be involved in cases of more serious misconduct or breaches of the rules, or persistent minor breaches which have not been remedied by informal counselling (see Clause 1 (D) above).  Normally the procedure will follow the stages listed below.

	
  

	
(i)

	
The first formal step is a verbal warning, administered by the Board.  The fact that a warning has been given, by whom, when, and for what reason will be recorded on the executive's personal file.  The Board will advise the executive of the standards of conduct required by her or her, and of the consequences of failure to maintain them.

	
  

	
(ii)

	
Stage 2 is a first formal written warning, administered by the Board.  A copy of the warning will be placed in the executive's personal file.  The warning will specify the matters of complaint against the executive.

	
  

	
(iii)

	
Stage 3 is a final written warning, administered by the Board.  The details of the warning will be as at stage 2, with relevant previous disciplinary action, the improvements in conduct required to be achieved and maintained, the duration of the warning and the consequences of failure to respond as required.  Additionally the warning will make it clear that further misconduct, breaches of rules or failure to comply with the warning will lead to the risk of dismissal.

	
  

	
(iv)

	
Stage 4 is dismissal.  Only the Board has the authority to dismiss.  Dismissal will be reserved for cases where the disciplinary procedure has failed to elicit acceptable standards of conduct from the executive, or cases of gross misconduct or serious breaches of the rules or action indicating unfitness for the responsibilities held by the executive.

	
  

	
(v)

	
Dismissal will take effect immediately (without prejudice to the executive's rights of appeal).  Payment in lieu of notice will be at the discretion of the Board.

 

  

20

  

3.           Investigation and Hearings

	
(A)

	
In all cases before taking disciplinary action the matter will be carefully investigated by the Board.  Investigations will be conducted as rapidly as circumstances permit.  The Board may suspend the executive during an investigation if this is considered advisable.

	
(B)

	
No disciplinary decision will be taken until the executive has been informed in writing of the nature of the complaint or allegations, the basis of the complaint and/or the allegations and of her rights under the procedure, and has been interviewed by the person empowered to take the relevant disciplinary action.

	
(C)

	
The executive will be given a reasonable opportunity to consider her response and will be afforded the opportunity to state her case to the disciplinary hearing, together with the executive's chosen representative or witness.

	
(D)

	
Disciplinary hearings will be held as soon as reasonably practicable.

4.           Appeals

	
(A)

	
After any disciplinary meeting, the executive will be informed of the decision made and of her/her rights of appeal.

(B)           Appeals against dismissal will be heard by the Board.

	
(C)

	
Appeals should be lodged in writing within seven days of the disciplinary decisions being notified to the executive.  The executive will be advised of the right of appeal and how and when to exercise it at that stage.  An appeal hearing will be heard as soon as reasonably practicable.

(D)           After the appeal hearing, the executive will be informed in writing of the final decision.

 

5.           Grievance Procedure

	
1.

	
If the executive has any grievance relating to any aspect of her or her employment she or she may first discuss the matter with one of the Board before raising the matter formally.

	
2.             In the event of the problem not being resolved after the above the executive will require to set out her grievance in writing and submit to the Board.

 

3.           The decision of the Board will be communicated in writing to the executive.

  

21

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00237-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00237-of-00352.parquet"}]]